Predicting HBEAG loss by HBV DNA early kinetics and HBV genotype during treatment of HBEAG+ chronic hepatitis B (CHB) patients with adefovir dipivoxil (ADV)
暂无分享,去创建一个
M. Wulfsohn | C. Gibbs | A. Neumann | M. Tsiang | C. Westland | S. Xiong | C. Brosgart | J. Fry | T. Ronen | Y. Havlin